The multicenter phase II study of opioid based pain control program for head and neck cancer patients recieving chemoradiotherapy

The multicenter phase II study of opioid based pain control program for head and neck cancer patients recieving chemoradiotherapy - SCHN-A001

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001048

Enrollment

110

Registered

2008-03-01

Start date

2008-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

Opioid based pain control program

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. be to recieve chemoradiotherapy including over 50 Gy irradiation for pharyngeal/ oral space 2. be to recieve treatment without radiation split over 1week 3. age:20-75 4. ECOG PS:0-1 5.adequate bone marrow fanction, laboratory parameters, hepatic fanction and renal fanction

Exclusion criteria

Exclusion criteria: 1 women who are pregnant or breast feeding 2 with mental disorder 3 recieve the systemic therapy of steroid continuously 4 have the history of Miocardial infarction within 3 months 5 recieve the opioid therapy for cancer pain 6 with sever active co-mobidity (COPD, interstitial pneumonitis, angina pectoris and so on) 7 with severe infectious disease 8 do not agree with constructing PEG 9 with collagenosis

Design outcomes

Primary

Measure	Time frame
The frequency of treatment interruption caused by severe stmatitis or mucocitis	—

Secondary

Measure	Time frame
the rate of completion of radiotherapy	—

Countries

Japan

Contacts

Public ContactSadamoto Zenda

National Cancer Center Hospital East Radiation Oncology Division

szenda@east.ncc.go.jp04-7133-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026